Medicine and Dentistry
Human Immunodeficiency Virus
100%
Wart Virus
64%
Oropharyngeal Cancer
32%
Malignant Neoplasm
27%
Papillomavirus Infection
26%
Head and Neck Cancer
24%
Cohort Analysis
23%
Prevalence
22%
Human Papillomavirus Type 16
19%
Infection
14%
Neoplasm
12%
Men Who Have Sex with Men
12%
Squamous Cell
12%
Cohort Effect
11%
Precancerous Condition
11%
Anal Cancer
11%
Oropharynx Squamous Cell Carcinoma
11%
Cancer Cell
11%
Neck
10%
Hazard Ratio
10%
Human Immunodeficiency Virus Infection
10%
Antiretroviral Therapy
10%
Cancer Risk
9%
Odds Ratio
8%
Disease
8%
P16
7%
Head and Neck Squamous Cell Carcinoma
6%
Cervical Cancer
6%
Cytotechnology
6%
Cancer Screening
6%
Papanicolaou Stain
6%
Biological Marker
6%
Non-Hodgkin Lymphoma
5%
Cell Count
5%
Oral Cavity
5%
COVID-19
5%
Cancer Epidemiology
5%
Keyphrases
High-risk Human Papillomavirus (HR-HPV)
43%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
33%
AIDS/HIV
32%
People Living with HIV (PLHIV)
30%
Confidence Interval
25%
Papillomavirus Infections
24%
HPV16
24%
Head-and-neck Cancer
23%
HIV Patients
21%
United States
19%
Oral Human Papillomavirus
18%
Multicenter AIDS Cohort Study
16%
Antiretroviral Therapy
12%
CD4 Count
12%
HIV-positive
11%
HIV Status
11%
Risk Factors
10%
Men Who Have Sex with Men
10%
Cervical Cancer
9%
HIV Infection
9%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
9%
Women's Interagency HIV Study
9%
North America
8%
Head-and-neck
8%
HIV-negative
7%
Canada
7%
Tumor
6%
Human Papillomavirus Vaccine
6%
Cancer Patients
6%
Living with
6%
Anal Cancer
6%
Adjusted Hazard Ratio
6%
HPV Positive
6%
Epidemiology
6%
Squamous Cell Cancer
6%
Human Papillomavirus Types
6%
Odds Ratio
5%
Cancer Risk
5%
Pooled Analysis
5%
COVID-19
5%
Non-Hodgkin Lymphoma
5%
Oncogenic Human Papillomavirus
5%
Natural History
5%
Oral Rinse
5%
Pap Test
5%
Nasopharyngeal Carcinoma
5%
HPV16 E7
5%
